Stalevo 100 and Pneumonia aspiration - a phase IV clinical study of FDA data

Summary:

Pneumonia aspiration is reported as a side effect among people who take Stalevo 100 (carbidopa; entacapone; levodopa), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Cilostazol, and have Bipolar i disorder.

The phase IV clinical study analyzes which people have Pneumonia aspiration when taking Stalevo 100. It is created by eHealthMe based on reports of 3,025 people who have side effects when taking Stalevo 100 from the FDA, and is updated regularly.

What is Stalevo 100?

Stalevo 100 has active ingredients of carbidopa; entacapone; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 3,093 Stalevo 100 users. Check the latest studies of Stalevo 100.

What is Pneumonia aspiration?

Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree) is found to be associated with 1,395 drugs and 1,617 conditions by eHealthMe. Check the latest studies of Pneumonia aspiration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

3,025 people reported to have side effects when taking Stalevo 100.
Among them, 28 people (0.93%) have Pneumonia aspiration.

Could Stalevo 100 cause Pneumonia aspiration?

Among these 28 people:

How long have people been on Stalevo 100 when they have Pneumonia aspiration? *

  • < 1 month: 25 %
  • 1 - 6 months: 75 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pneumonia aspiration when taking Stalevo 100? *

  • female: 53.57 %
  • male: 46.43 %

What is the age of people who have Pneumonia aspiration when taking Stalevo 100? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Stalevo 100? *

  1. Cilostazol: 5 people, 17.86%
  2. Depakote: 4 people, 14.29%
  3. Haldol: 4 people, 14.29%
  4. Levothyroxine Sodium: 4 people, 14.29%
  5. Oxazepam: 4 people, 14.29%
  6. Captopril: 4 people, 14.29%
  7. Aspirin: 3 people, 10.71%
  8. Enalapril Maleate: 3 people, 10.71%
  9. Paxil: 3 people, 10.71%
  10. Requip: 2 people, 7.14%

What are other side effects people have besides Pneumonia aspiration? *

  1. Swallowing Difficulty: 8 people, 28.57%
  2. Anaemia (lack of blood): 7 people, 25.00%
  3. Confusional State: 7 people, 25.00%
  4. Weakness: 6 people, 21.43%
  5. Agitation (state of anxiety or nervous excitement): 5 people, 17.86%
  6. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 5 people, 17.86%
  7. Insomnia (sleeplessness): 5 people, 17.86%
  8. Disturbance In Attention: 5 people, 17.86%
  9. Consciousness - Decreased: 4 people, 14.29%
  10. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 4 people, 14.29%

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 14.29%
  2. Drug Dependence: 4 people, 14.29%
  3. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 14.29%
  4. High Blood Pressure: 3 people, 10.71%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.14%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 7.14%
  7. Abnormal Behavior: 2 people, 7.14%
  8. Headache (pain in head): 1 person, 3.57%
  9. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 3.57%
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Stalevo 100 and have Pneumonia aspiration?

- Check whether Pneumonia aspiration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stalevo 100:

Pneumonia aspiration treatments and more:

How severe was Pneumonia aspiration and when was it recovered:

Expand to all the drugs that have ingredients of carbidopa; entacapone; levodopa:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stalevo 100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia aspiration:

Browse all the conditions that are associated with Pneumonia aspiration:


How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; entacapone; levodopa (the active ingredients of Stalevo 100) and Stalevo 100 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: